Literature DB >> 28767961

[Use of industrial liquid silicone to transform the body: prevalence and factors associated with its use among transvestites and transsexual women in São Paulo, Brazil].

Thiago Pestana Pinto1, Flavia do Bonsucesso Teixeira2, Claudia Renata Dos Santos Barros3, Ricardo Barbosa Martins4, Gustavo Santa Roza Saggese1, Daniel Dutra de Barros1, Maria Amelia de Sousa Mascena Veras1.   

Abstract

This study aimed to estimate the prevalence of use of industrial liquid silicone (ILS) among transvestite persons and transsexual women and identify associated factors. This was a cross-sectional study in seven municipalities in São Paulo State, Brazil, with data collected in 2014 and 2015 in a sample of 576 individuals. Analysis of the associated factors used a Poisson model with robust variance to estimate the crude and adjusted prevalence ratios. Prevalence of use of ILS was 49%, mean age at first injection of ILS was 22 (± 5.3) years, and 43% reported health problems resulting from its use. Having less than a university education, age 20 years and older, self-identification as transvestite, and sex work were positively associated with use of ILS according to the multivariate model. There was a high prevalence of ILS use and resulting health problems, indicating the need to prevent its use and reduce the resulting health problems. It is thus essential to ensure access to the necessary resources for body changes during transition through comprehensive care for transvestites and transsexual persons in the Brazilian Unified National Health System (SUS). Finally, health policies should include demands for body changes as part of gender identity construction, respecting each person's unique needs in this transition process.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28767961     DOI: 10.1590/0102-311X00113316

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  5 in total

1.  Awareness, Willingness, and PrEP Eligibility Among Transgender Women in Rio de Janeiro, Brazil.

Authors:  Emilia M Jalil; Beatriz Grinsztejn; Luciane Velasque; Alessandra Ramos Makkeda; Paula M Luz; Ronaldo I Moreira; Luciana Kamel; Nilo M Fernandes; Ana Cristina G Ferreira; Brenda Hoagland; Sandra Wagner; Albert Liu; Willi McFarland; Susan Buchbinder; Valdilea G Veloso; Erin Wilson
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

2.  Optimising HIV programming for transgender women in Brazil.

Authors:  Jae Sevelius; Laura Rebecca Murray; Nilo Martinez Fernandes; Maria Amelia Veras; Beatriz Grinsztejn; Sheri A Lippman
Journal:  Cult Health Sex       Date:  2018-10-31

3.  Nonprescribed Sex Hormone Use Among Trans Women: The Complex Interplay of Public Policies, Social Context, and Discrimination.

Authors:  Luca F Maschião; Francisco I Bastos; Erin Wilson; Willi McFarland; Caitlin Turner; Thiago Pestana; Maria Amélia Veras
Journal:  Transgend Health       Date:  2020-12-11

4.  PURTSCHER-LIKE RETINOPATHY AND PARACENTRAL ACUTE MIDDLE MACULOPATHY CAUSED BY INDUSTRIAL SILICONE EMBOLISM.

Authors:  Bruno Mauricio Rodrigues de Oliveira; Leonardo Moraes de Souza; Gabriel Costa Andrade; Claudio Zett Lobos; Eduardo Cunha de Souza; Nilva Simeren Bueno de Moraes
Journal:  Retin Cases Brief Rep       Date:  2020-02-19

5.  Peer Navigation to Support Transgender Women's Engagement in HIV Care: Findings from the Trans Amigas Pilot Trial in São Paulo, Brazil.

Authors:  Sheri A Lippman; Jae M Sevelius; Gustavo Santa Roza Saggese; Hailey Gilmore; Katia Cristina Bassichetto; Daniel Dutra de Barros; Renata Batisteli de Oliveira; Luca Fasciolo Maschião; Dorothy Chen; Maria Amelia de Sousa Mascena Veras
Journal:  AIDS Behav       Date:  2022-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.